346 related articles for article (PubMed ID: 31819163)
1. Pharmacogenomic phase transition from personalized medicine to patient-centric customized delivery.
Radhakrishnan A; Kuppusamy G; Ponnusankar S; Shanmukhan NK
Pharmacogenomics J; 2020 Feb; 20(1):1-18. PubMed ID: 31819163
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics, precision medicine, and implications for anesthesia care.
Kaye AD; Mahakian T; Kaye AJ; Pham AA; Hart BM; Gennuso S; Cornett EM; Gabriel RA; Urman RD
Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):61-81. PubMed ID: 30322465
[TBL] [Abstract][Full Text] [Related]
3. Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.
Johnson JA; Burkley BM; Langaee TY; Clare-Salzler MJ; Klein TE; Altman RB
Clin Pharmacol Ther; 2012 Oct; 92(4):437-9. PubMed ID: 22910441
[TBL] [Abstract][Full Text] [Related]
4. Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management.
Soni A; Gowthamarajan K; Radhakrishnan A
Int J Pharm Compd; 2018; 22(2):108-121. PubMed ID: 29877858
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
[TBL] [Abstract][Full Text] [Related]
6. [Personalized Medicine: A big promise for the future].
Ertl G
Dtsch Med Wochenschr; 2015 Oct; 140(20):1483-4. PubMed ID: 26445248
[No Abstract] [Full Text] [Related]
7. Theoretical Formulation Strategies towards Neutralizing Inter-individual Variability Associated with Tacrolimus Immunosuppressant Therapy: A Case Study on Nextgeneration Personalized Medicine.
Radhakrishnan A; Kuppusamy G
Curr Drug Metab; 2021; 22(12):939-956. PubMed ID: 34779367
[TBL] [Abstract][Full Text] [Related]
8. Future prospects for pharmacogenetics in the quest for personalized medicine.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2012 Dec; 50(12):13-6. PubMed ID: 23457712
[TBL] [Abstract][Full Text] [Related]
9. Opinion Paper: Modular Drug Delivery Systems for Personalized Oral Dosage Forms.
Colombo P
Recent Pat Drug Deliv Formul; 2016; 10(1):3. PubMed ID: 26063397
[No Abstract] [Full Text] [Related]
10. Pharmacogenomics knowledge for personalized medicine.
Whirl-Carrillo M; McDonagh EM; Hebert JM; Gong L; Sangkuhl K; Thorn CF; Altman RB; Klein TE
Clin Pharmacol Ther; 2012 Oct; 92(4):414-7. PubMed ID: 22992668
[TBL] [Abstract][Full Text] [Related]
11. Integrating pharmacogenomics into electronic health records with clinical decision support.
Hicks JK; Dunnenberger HM; Gumpper KF; Haidar CE; Hoffman JM
Am J Health Syst Pharm; 2016 Dec; 73(23):1967-1976. PubMed ID: 27864204
[TBL] [Abstract][Full Text] [Related]
12. Personalized medicine, pharmacogenomic and companion biomarker.
Manceau H; Amrani K; Peoc'h K
Ann Biol Clin (Paris); 2017 Dec; 75(6):631-636. PubMed ID: 29192598
[TBL] [Abstract][Full Text] [Related]
13. Semantically enabling pharmacogenomic data for the realization of personalized medicine.
Samwald M; Coulet A; Huerga I; Powers RL; Luciano JS; Freimuth RR; Whipple F; Pichler E; Prud'hommeaux E; Dumontier M; Marshall MS
Pharmacogenomics; 2012 Jan; 13(2):201-12. PubMed ID: 22256869
[TBL] [Abstract][Full Text] [Related]
14. Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experience.
Aquilante CL; Kao DP; Trinkley KE; Lin CT; Crooks KR; Hearst EC; Hess SJ; Kudron EL; Lee YM; Liko I; Lowery J; Mathias RA; Monte AA; Rafaels N; Rioth MJ; Roberts ER; Taylor MR; Williamson C; Barnes KC
Pharmacogenomics; 2020 Apr; 21(6):375-386. PubMed ID: 32077359
[TBL] [Abstract][Full Text] [Related]
15. Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program.
Shuldiner AR; Palmer K; Pakyz RE; Alestock TD; Maloney KA; O'Neill C; Bhatty S; Schub J; Overby CL; Horenstein RB; Pollin TI; Kelemen MD; Beitelshees AL; Robinson SW; Blitzer MG; McArdle PF; Brown L; Jeng LJ; Zhao RY; Ambulos N; Vesely MR
Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):76-84. PubMed ID: 24616408
[TBL] [Abstract][Full Text] [Related]
16. Nanochannel systems for personalized therapy and laboratory diagnostics.
Grattoni A; Fine D; Ziemys A; Gill J; Zabre E; Goodall R; Ferrari M
Curr Pharm Biotechnol; 2010 Jun; 11(4):343-65. PubMed ID: 20199382
[TBL] [Abstract][Full Text] [Related]
17. The Daniel K. Inouye College of Pharmacy Scripts: Precision Medicine Through the Use of Pharmacogenomics: Current Status and Barriers to Implementation.
Ciarleglio AE; Ma C
Hawaii J Med Public Health; 2017 Sep; 76(9):265-269. PubMed ID: 28900583
[TBL] [Abstract][Full Text] [Related]
18. Conference scene: pediatric pharmacogenomics and personalized medicine.
Leeder JS; Lantos J; Spielberg SP
Pharmacogenomics; 2010 Dec; 11(12):1691-702. PubMed ID: 21142913
[TBL] [Abstract][Full Text] [Related]
19. Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
Russell LE; Schwarz UI
Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics and personalized medicine in clinical practice.
Manolopoulos VG; Dechairo B; Huriez A; Kühn A; Llerena A; van Schaik RH; Yeo KT; Ragia G; Siest G
Pharmacogenomics; 2011 May; 12(5):597-610. PubMed ID: 21619425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
